⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 3, 2024Open Access

Supplementary Figure S1 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study

David J. Pinato Antonio D’Alessio Claudia Angela Maria Fulgenzi Alexandra Emilia Schlaak Ciro Celsa Saskia Killmer Jesús Miguéns Blanco Caroline Ward Charalampos‐Vlasios Stikas Mark R. Openshaw Nicole Acuti Georgios Nteliopoulos Cristina Balcells Hector C. Keun Robert Goldin Paul J. Ross Alessio Cortellini Robert Thomas Anna-Mary Young Nathan Danckert Paul Tait Julian R. Marchesi Bertram Bengsch Rohini Sharma

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S1. HCC-specific targeted mutation panel utilised for NGS and quality filters implemented for variant calling.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pinato et al. (2024) studied this question.

synapsesocial.com/papers/68e6672fb6db6435875f3aa8 https://doi.org/10.1158/1078-0432.25956667

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S1 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
2Supplementary Figure S2 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
3Supplementary Figure S2 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
4Supplementary Figure S12 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024
5Supplementary Figure S12 from Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study2024